Molnupiravir is an investigational oral antiviral drug currently being studied in a Phase 3 trial for the treatment of non-hospitalized patients with confirmed COVID-19
The company is pursuing specific goals in the areas of science and technology, value chain as well as climate and the environment.
The company will add a single-use assembly production unit at its Life Science Center in Molsheim, France.
Has signed a 12-year, off-site, virtual power purchase agreement (VPPA) with Enel Green Power
Merck forecasts organic growth of EBITDA pre in a high single-digit to low teens percentage range in 2021.
The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy
The initiative aims to encourage women and parents to seek timely medical guidance on cervical cancer prevention and HPV awareness
Healthcare and consumer wellness leader brings extensive experience in business transformation, commercial strategy and growth leadership to Fertin India
In his new role, Gregory will drive partnerships for the company’s large-scale molecule biologics business across Europe
Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally
Subscribe To Our Newsletter & Stay Updated
